Autoimmune gastrointestinal dysmotility following SARS-CoV-2 infection successfully treated with intravenous immunoglobulin.

Mayra MontalvoPadmini NallapaneniSara HassanSamuel NurkoSean J PittockJulie Khlevner

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)

This is the first report of AGID occurring after SARS-CoV-2 infection. The dramatic response to IVIG emphasizes the importance of early recognition and the reversible and treatable nature of this condition.

Keyphrases

respiratory syndrome coronavirus
multiple sclerosis
high dose
sars cov
coronavirus disease
low dose